ERBB2 and breast cancer: Pathological biomarkers such as estrogen receptor (ER), progesterone receptor (PgR), ErbB2, Ki‐67, cytokeratins, and epidermal growth factor (EGF) receptor are mainly used in clinical situations to define breast cancer subtypes.